The present study is part of a large-scale investigation of the antitumor effects of Biophytum sensitivum on B16F-10 melanoma cells. The investigation involved the regulatory effect of B sensitivum on nitric oxide and cytokine production in B16F-10 cells, tumor-associated macrophages, and peritoneal macrophages as well as on the apoptotic process in B16F-10 melanoma cells. B sensitivum at a concentration of 10 µ µg/mL could significantly (P < < .001) inhibit production of nitric oxide and proinflammatory cytokines such as interleukin-1β β, interleukin-6, granulocyte monocyte-colony stimulating factor, and tumor necrosis factor -α α in B16F-10 cells, tumor-associated macrophages, and peritoneal macrophages. Incubation of B16F-10 cells with B sensitivum showed the presence of apoptotic bodies and induced DNA fragmentation. Furthermore, B sensitivum showed an inhibitory effect on inducible nitric oxide synthase as well as bcl-2 expression, and up-regulated p53 and caspase-3 messenger RNA expression in B16F-10 melanoma cells. The observed results suggest that regulation of proinflammatory cytokine production by tumor cells, tumor-associated macrophages, and resident macrophages accompanied by altered inducible nitric oxide synthase, bcl-2, caspase-3, and p53 messenger RNA expression by B sensitivum methanol extract induces apoptosis in B16F-10 melanoma cells.
Treatment of cancer can be as debilitating as the disease. Therefore, prevention of cancer could be considered as important as treatment. Natural products can play a vital role in cancer prevention. Herbal medicines derived from plant extracts are increasingly being used to treat a wide variety of clinical conditions, with relatively little knowledge of their modes of action. Studies have shown that several plant-based drugs can be associated with a reduced risk of cancer. 1, 2 Apoptosis is an inducible form of controlled cell death that is essential for normal human embryogenesis as well as homeostatic state and protective processes. 3 It has an essential role in controlling cell number in many developmental and physiological conditions. Apoptosis is impaired in many human tumors, suggesting that disruption of apoptotic function contributes substantially to the transformation of normal cells into tumor cells, an important event in chemotherapy-induced tumor-cell killing. Components of the apoptosis signaling cascade include caspases along with several other triggers and regulators. 3, 4 Agents that are capable of inducing selective apoptosis of cancer cells are being given great interest in developing novel cancer preventive approaches. Recently, research on herbal medicines for cancer prevention has focused on agents that are actively capable of selective or preferential elimination of cancer cells by causing apoptosis. A variety of studies have suggested the apoptotic effect of natural products in various cell lines. 5, 6 We previously reported that β-carotene, a bioactive compound present in fruits and vegetables, could induce apoptosis in B16F-10 melanoma cells. 7 Biophytum sensitivum (L.) DC (Oxalidaceae) has been used as food and in traditional Asian medicine to treat adult diseases such as diabetes and inflammation. 8, 9 We previously reported that B sensitivum possesses antioxidant, 10 antiangiogenic, 11 chemoprotective, 12 antitumor, and immunomodulatory 13 effects. Recently, it was reported that B sensitivum contains flavonoids such as luteolin 7-methyl ester and isoorientin and biflavones such as cupressuflavone and amentoflavone. 14 Our recent reports suggest that B sensitivum could inhibit the activation and nuclear translocation of p65, p50, and c-Rel subunits of nuclear factor (NF)-κB as well as other transcription factors such as c-fos, activating transcription factor-2, and CREB in B16F-10 melanoma cells. 15 However, the molecular mechanisms associated with the stimulation of apoptotic cell death by this plant are not fully understood. The present study was designed to investigate the role of B sensitivum in the regulation of nitric oxide (NO) and cytokine release from activated murine macrophages, tumor-associated macrophages, and highly metastatic B16F-10 melanoma cells. Also the molecular mechanism associated with the stimulation of apoptotic cell death in B16F-10 melanoma cells was studied by examining the regulatory effect of B sensitivum on bcl-2, caspase-3, and p53 genes. Because NO and several proinflammatory cytokines play an important role in the apoptotic process, 16 we investigated the effect of B sensitivum on the regulation of NO and cytokine release from activated murine macrophages, tumor-associated macrophages, and B16F-10 melanoma cells.
Materials and Methods
Animals BALB/c and C57BL/6 mice were purchased from National Institute of Nutrition (Hyderabad, India). The animals were maintained in ventilated cages, fed with normal mouse chow (Sai Feeds, Mumbai, India), and given water ad libitum. All the animal experiments were performed according to the rules and regulations of the Animal Ethics Committee, Government of India.
Chemicals
Dulbecco's modified Eagle's medium (DMEM) and minimum essential medium were purchased from HiMedia Laboratory, Mumbai. Cells-to-complementary DNA (cDNA) kit was purchased from Ambion Inc (Austin, Tex). Oligonucleotide primer sequences of genes for reverse transcription-polymerase chain reaction (RT-PCR) were purchased from Maxim Biotech Inc (San Francisco, Calif). All other reagents used were of analytical reagent grade.
Cell Line
B16F-10 melanoma cells were obtained from the National Centre for Cell Science (Pune, India). The cells were maintained in DMEM supplemented with 10% fetal calf serum (FCS) and antibiotics.
Enzyme-Linked Immunosorbent Assay (ELISA) Kit
Highly specific quantitative sandwich ELISA kits for mouse interleukin (IL)-1β, IL-6, granulocyte monocytecolony stimulating factor (GM-CSF), and tumor necrosis factor (TNF)-α were purchased from Pierce Endogen (Rockford, Ill).
Isolation of Macrophages and Tumor-Associated Macrophages
Peritoneal macrophages were elicited by injecting 0.2 mL of sodium caseinate (intraperitoneally) followed by lavage of the peritoneal cavity on the 5th day after sodium caseinate injection in BALB/c mice.
Tumor-associated macrophages (TAMs) were isolated from B16F-10 solid tumor C57BL/6 carriers. Solid tumors (3-4 weeks old) were dissected and mashed aseptically in RPMI-1640, and the cell suspension was kept undisturbed for 2 hours at 37°C. The supernatant was discarded and the adhered macrophages were scraped out using a rubber policeman. Peritoneal macrophages as well as TAMs were cultured in RPMI-1640 supplemented with 10% (vol/vol) FCS and antibiotics.
Extract Preparation
Authenticated B sensitivum was collected from Amala Ayurveda Pharmacy (Thrissur, India). A voucher specimen with number ACRC-Ox 07 was deposited at the herbarium of Amala Cancer Research Centre (Thrissur, India). The air-dried whole plant (100 g) was powdered and extracted overnight by maceration with 10 volumes of 75% methanol. The solvent was evaporated to dryness at 42°C under reduced pressure using a rotary evaporator. The yield of the extract was 12%. The extract was resuspended in 1% gum acacia in phosphate-buffered saline. This was intraperitoneally administered to the animals at a concentration of 50 mg/kg body weight. For in vitro experiments, the extract was dissolved in dimethyl sulfoxide (DMSO) and diluted in the medium so that the final concentration of DMSO was less than 0.1% vol/vol.
Morphological Analysis and DNA Ladder Studies
B16F-10 cells (5000 cells/well) were cultured in the presence and absence of B sensitivum (10 µg/mL) at 37°C in 5% CO 2 atmosphere for 48 hours. The cells were washed twice with phosphate-buffered saline (pH 7.4), fixed with 5% formalin, and stained with hematoxylin and eosin. Apoptosis was characterized by examining the morphological changes such as chromatin condensation, nuclear condensation, membrane blebbing, or presence of apoptotic bodies.
To detect the change in DNA pattern, the cells (1 × 10 6 cells) were treated with 0.1 mL of lysis buffer (100 mM Tris HCl, pH 8.0, and 1 mM EDTA). DNA samples were separated by electrophoresis in 1% agarose gels. DNA was stained with ethidium bromide and photographed under ultraviolet light.
Studies on the Expression of Inducible Nitric Oxide Synthase (iNOS), bcl-2, p53, and Caspase-3 by RT-PCR
Logarithmically growing B16F-10 cells (5 × 10 4 ) were incubated for 4 hours in the presence and absence of B sensitivum at a concentration of 10 µg/mL. cDNA was synthesized using the Cells-to-cDNA kit (Ambion Inc). Cells from tissue culture were washed with phosphatebuffered saline and heated in cell lysis buffer (provided in the kit) to release the RNA into the solution. This was followed by a heating step to inactivate endogenous ribonucleases. The genomic DNA was further degraded by treating with deoxyribonuclease (DNase) followed by inactivation of DNase by heating at 70°C. Reverse transcription was performed at 42°C for 50 minutes using Moloney murine leukemia virus RT (supplied along with the kit). Gene expression studies were performed by PCR analysis. The mouse iNOS (forward 5′-CTTCAACACCAAGGTTGTCTGCAT-3′ and reverse 3′-ATGTCATGAGCAAAGGCGCAGAAC-5′), bcl-2 (forward 5′-CAGCTGCACCTGACGCCCTT-3′ and reverse 3′-CCCAGCCTCCGTTATTCTGGA-5′), p53 (forward 5′-CGGAGGTCGTGAGACGCTG-3′ and reverse 3′-CACATGTACTTGTAGTGGATGGTGG-5′), and caspase-3 (forward 5′-GAGCACTGGAATGTCAT CTCGCTCTG-3′ and reverse 3′-TACAGGAAGTCAGC-CTCCACCGGTATC-5′) genes were amplified against glyceraldehyde 3-phosphate dehydrogenase (5′-CGTC-CCGTAGACAAAATGGT-3′ and reverse 3′-TTGAAAC-CGTAACACCTTCC-5′) standard. The standard PCR products were generated by using positive control cDNA provided in the kit. The cycling conditions were as follows: 1 minute at 94°C, 1 minute at 58°C, and 1 minute at 72°C for 40 cycles, followed by a 10minute extension at 72°C. Amplified PCR products were electrophoresed on a 1.8% agarose gel, stained with ethidium bromide, and photographed under ultraviolet light.
Determination of the Effect of B sensitivum on the Production of Nitrite by B16F-10 cells, TAMs, and Peritoneal Macrophages B16F-10 cells, TAMs, and peritoneal macrophages were seeded in a 96-well titer plate at a density of 5000 cells/well in medium supplemented with 10% FCS and antibiotics. The cells were cultured in the presence and absence of escalating concentrations of B sensitivum (1-10 µg/mL) for 24 hours at 37°C with 5% CO 2 . After 24 hours, the plates were centrifuged and the supernatant was used for the estimation of nitrite by Griess reaction. 17
Determination of the Effect of B sensitivum on IL-1β β, IL-6, GM-CSF, and TNF-α α Produced by B16F-10 Cells, TAMs, and Peritoneal Macrophages
The cell supernatant from the above experiment was collected and centrifuged, and the concentrations of IL-1β, IL-6, GM-CSF, and TNF-α were determined by quantitative ELISA (Endogen, Rockford, Ill) according to the manufacturer's directions.
Statistical Analysis
Values are expressed as mean ± SD. Statistical analysis was performed via one-way analysis of variance followed by Dunnett's test using GraphPad Instat version 3.00 for Windows 95 (GraphPad Software, San Diego, Calif).
Results

Inhibition of Nitrite by B sensitivum
The effect of B sensitivum on the release of nitrite by B16F-10, TAMs, and peritoneal macrophages is shown in Figures 1, 2 , and 3, respectively. B sensitivum at a concentration of 1, 5, and 10 µg/mL reduced the nitrite production to 14.2, 10.8, and 6.4 µM, respectively, from B16F-10 cells. Untreated B16F-10 cells produced nitrite at a concentration of 18 µM. Similarly, the increased levels of nitrite production in TAMs (23.6 µM) and peritoneal macrophages (16.98 µM) were also decreased by B sensitivum treatment. 10 µg/mL significantly (P < .001) reduced the proinflammatory cytokine production (Table 1) by the B16F-10 cells. Similarly, the higher levels of proinflammatory cytokine production in TAMs and peritoneal macrophages were found to be inhibited by B sensitivum treatment (Table 1) . B sensitivum at concentrations of 1 µg/mL and 5 µg/mL did not produce any significant changes in cytokine production (data not shown).
Effect of B sensitivum on
Morphology and DNA Fragmentation
Microscopic evaluation of B16F-10 cells treated with B sensitivum confirmed the presence of apoptotic bodies (Figure 4) . The presence of cells with apoptotic bodies in cultured cells treated with cytotoxic agents has been linked to DNA fragmentation associated with apoptosis. 18 Typical results from B16F-10 cells are shown in Figure 5 .
Effect of B sensitivum on the Expression of iNOS, bcl-2, p53, and Caspase-3
iNOS, bcl-2, p53, and caspase-3 genes were amplified against glyceraldehyde 3-phosphate dehydrogenase housekeeping gene. The effect of B sensitivum on the expression of iNOS is shown in Figure 6 . We found that treatment with B sensitivum (10 µg/mL) could down-regulate the expression of the iNOS gene. Lane 1 shows the amplified positive control iNOS included in the kit. Control cells showed very high expression of iNOS, but treatment with B sensitivum down-regulated the expression of iNOS gene.
The effect of B sensitivum on the expression of bcl-2, p53, and caspase-3 gene is shown in Figure 6 . B sensitivum treatment down-regulated the expression of bcl-2 and up-regulated the expression of p53 and caspase-3 genes in B16F-10 cells.
Discussion
Herbal drugs are recognized as cancer chemopreventive agents. Several plant extracts and isolated compounds are especially well known to suppress tumor cell growth via induction of apoptosis in several tumor cell lines. 7, 19 Biophytum sensitivum has been shown to exhibit antiangiogenic and antimetastatic effects. 11, 15 However, the mechanism by which B sensitivum suppresses angiogenesis and metastasis has not been fully elucidated. The present study is part of a large-scale investigation of antitumor effects of B sensitivum on B16F-10 melanoma cells and its influence on tumor-associated macrophages and peritoneal macrophages.
Nitric oxide is a gaseous molecule synthesized via the oxidation of L-arginine by a family of nitric oxide synthases (NOS), which are either constitutive (cNOS) or inducible (iNOS). 20 The induction of iNOS can lead to the sustained production of high concentrations of NO. The role of NO in tumor development is ambiguous. When produced by tumor cells, NO may induce vasodilation, resulting in enhanced permeability in tumor vasculature. In such cases, the blood flow in the tumor will be increased, which would provide a favorable condition for the tumor. 21 by iNOS is a mediator involved in different processes, such as neurotransmission, and it can affect the vasculature. The present study is of potential importance because iNOS is overly expressed in various types of tumors, 22 and any compound that can inhibit the expression of iNOS is of practical value. Apart from tumor cells, various cells such as macrophages and tumor-associated macrophages are involved in the process of inflammation and carcinogenesis. 23, 24 These cells mediate inflammatory reactions by synthesizing and releasing a variety of mediator molecules, including NO, arachidonic acid metabolites, and cytokines. 25, 26 In the present study, B sensitivum was found to inhibit nitrate levels in B16F-10 melanoma cells, TAMs, and peritoneal macrophages. During tumor development, the cross-talk between inflammatory cells and surrounding cells is crucial. With regard to the cross-talk between inflammatory cells and endothelial cells present in the tumor microenvironment, IL-1β stimulates the proliferation of endothelial cells, expression of adhesion molecules, and production of cytokines and inflammatory molecules in vitro, suggesting that IL-1-related molecules may be deeply involved in the control of angiogenesis. 27, 28 The relevance of microenvironmental IL-1 in angiogenesis and in the invasiveness of different tumor cells has been recently demonstrated using IL-1β knockout mice. 29 IL-1β up-regulates hypoxia inducible factor-1α in a human lung cancer cell line (A549), activating the NF-κB/Cox-2 pathway. 30 Increasing evidence suggests that TNF-α may regulate many critical processes of tumor promotion and progression. Murine models have confirmed that TNF-α is an important cytokine mediator of cancer cachexia, in addition to IL-1, IL-6, and interferon-γ. 31, 32 TNF-α plays an important role in the initiation and progression of the inflammatory response, and it causes polymorphonuclear neutrophil influx, vascular endothelial adhesion molecule expression, and release of proinflammatory mediators. 33, 34 IL-6 is a growth factor for hematologic malignancies and has been found to stimulate vascular endothelial growth factor. 35 GM-CSF has been shown to have megakaryocyte potentiating activity attributable to IL-6; GM-CSF also has been shown to cause thrombocytosis 36 and thereby participate in pathogenesis of tumor metastasis. In patients with head and neck squamous carcinoma, proinflammatory cytokines such as IL-6 and GM-CSF are highly expressed. 37 Our studies revealed that B sensitivum could inhibit the production of IL-1β, TNF-α, IL-6, and GM-CSF in B16F-10 melanoma cells, TAMs, and peritoneal macrophages, although the mechanism remains unclear.
Apoptosis is a biochemically regulated and active cell death program whereby individual cells die without injuring neighboring cells or causing inflammatory reaction. 38 During this process, the dying cell separates from its neighbors and undergoes a period of membrane blebbing, condensation of cytoplasm, and increase in cell density. Simultaneously, the nuclear chromatin becomes compact, segregates, and forms sharply delineated masses along the nuclear envelope. The nucleus splits into discrete fragments, and finally the cell splits into a cluster of membrane-bound apoptotic bodies, each containing a variety of organelles. Structural analysis of apoptotic proteins and studies of their biochemical mechanisms have suggested strategies for lead generation, resulting in numerous novel chemical entities with mechanism-based activity. Many of the most logical targets for promoting apoptosis of cancer cells are technically challenging, often involving disrupting protein interactions or altering gene expression, as opposed to traditional pharmaceuticals that attack enzymes. In the present study we evaluated the regulatory effect of B sensitivum on the expression of bcl-2, caspase-3, and p53 genes in B16F-10 melanoma cells.
The bcl-2 family is crucial in determining cell fate in the apoptotic pathway. Members of the bcl-2 family influence mitochondrial membrane polarization and the cleavage-mediated caspase activation, which are the ultimate effectors in apoptosis signaling. Although little is known about the transcriptional factors that control the expression of bcl-2-related proteins, NF-κB is a known transcriptional factor involved in their regulation. Diminished expression of bcl-2 has been observed in cell types undergoing apoptosis. [39] [40] [41] Naturally occurring substances such as garlic, curcumin, and hibiscus protocatechuic acid have been reported to induce apoptosis in carcinoma cell lines by decreasing bcl-2 expression. 39, 40, 42 p53 protein is a DNA-binding protein with a sequence-specific DNA binding region in the core domain, 43 and it has transcriptional activities in its target genes such as p21 44 and topoisomerase IIα, 45 which control many types of biologic functions. p53 protein normally plays an essential role in cancer prevention and apoptosis. Activation of p53 protein induces expression of MDM 2, which in turn inhibits the activation of p53, resulting in a short life and low expression of p53 under normal physiologic conditions. Thus, p53 is maintained at standby levels in the absence of cellular stress in most cells. 46 During cellular stress, p53 protein is phosphorylated and conducted to form a p53/MDM 2 interaction, resulting in apoptosis. 47 In the present study, we investigated the importance of bcl-2 and p53 in B sensitivum-induced apoptosis in B16F-10 melanoma cells. Decreased expression of bcl-2, as well as increased expression of p53, was observed after the exposure of melanoma cells to B sensitivum, which indicated that bcl-2-and p53-regulated apoptosis was indeed involved in B sensitivum-induced apoptosis. It is known that caspases are specific proteases of apoptosis, particularly caspase-3. 48 We examined whether the apoptotic effect of B sensitivum treatment in B16F-10 melanoma cells could be linked to a variation in caspase-3 expression. In fact, B sensitivum was found to induce caspase-3 expression. Activated caspase-3 has been shown to cleave specific substrates including the nuclear protein PARP, involved in DNA repair and genomic maintenance. 49 Our data suggest that B sensitivum triggers cell death through activation of caspase-3 in B16F-10 melanoma cells.
It has been shown that expression of functional p53 in conjunction with iNOS promotes NO-mediated apoptosis in tumor cells. 50 In our study, B sensitivum was found to up-regulate the expression of p53 and down-regulate the expression of iNOS, showing that apoptosis is not NO mediated. Because NO is produced by other inflammatory cells, such as TAMs and elicited macrophages, we evaluated the regulatory effect of B sensitivum on NO production in these cells. Our results indicate that B sensitivum could inhibit the NO production in these cells, which again confirms that apoptosis is not NO mediated. Also, B sensitivum inhibited the production of proinflammatory cytokines such as IL-1β, TNF-α, IL-6, and GM-CSF in B16F-10 melanoma cells, TAMs, and elicited macrophages. The reasons for this remain unclear. We believe that apoptosis induction by B sensitivum is one of the possible mechanisms and could account for its antineoplastic activities. Activation of caspase-3 as well as p53 and down-regulation of bcl-2 might play an important role in B sensitivum-induced apoptosis in B16F-10 melanoma cells. The data presented here contribute further to understanding the possible mechanisms of anticancer activity of B sensitivum.
Conclusions
The present study suggests that B sensitivum could stimulate apoptosis in B16F-10 melanoma cells by regulating bcl-2, p53, and caspase-3 genes and could regulate the NO and proinflammatory cytokine production in B16F-10 melanoma cells, TAMs, and elicited macrophages. Recently, it has been demonstrated that B sensitivum possesses pharmacologically active compounds such as luteolin 7-methyl ester, isoorientin, amentoflavone, and cupressuflavone. 14 The apoptotic effect on tumor cells by B sensitivum might be attributable to the presence of these compounds. Further studies using isolated compounds are in progress in our laboratory and will be reported shortly.
